Back to top
more

Universal Health Services (UHS)

(Real Time Quote from BATS)

$236.04 USD

236.04
169,135

+1.35 (0.58%)

Updated Sep 19, 2024 01:06 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 1% (3 out of 251)

Industry: Medical - Hospital

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Here's Why You Should Retain McKesson Stock in Your Portfolio Now

by Zacks Equity Research

MCK's strategic collaborations and strength in Biologics raise optimism about the stock.

GEHC Stock Rises as FDA Clears MIM Software's Centiloid Tool

by Zacks Equity Research

GE Healthcare's MIM Software announces the receipt of FDA clearance for its Centiloid scaling tool to perform PET-based amyloid imaging.

BD Stock Rises as Neopak XtraFlow Syringe Expands in Biologics

by Zacks Equity Research

BDX launches the Neopak XtraFlow Glass Prefillable Syringe, enhancing drug delivery for biologics and expanding capacity with new high-volume production lines.

Select Medical Rises 50.2% YTD: Take Profits or Bet on More Gains?

by Zacks Equity Research

SEM's profitability is being impacted by rising costs and expenses.

Here's Why Universal Health Services (UHS) is a Strong Value Stock

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks.com featured highlights include Century Communities, Powell Industries, Sylvamo, IAMGOLD and Universal Health Services

by Zacks Equity Research

Century Communities, Powell Industries, Sylvamo, IAMGOLD and Universal Health Services have been highlighted in this Screen of The Week article.

Teladoc Stock Rises 12% as Jefferies Boosts Price Target on BetterHelp

by Zacks Equity Research

TDOC's stock benefits from improving web traffic in its BetterHelp platform.

Merit Medical Stock Falls Despite Positive WRAPSODY Trial Results

by Zacks Equity Research

MMSI announces 6-month results from its WRAPSODY WAVE trial, showing superior efficacy in extending AV fistula patency for dialysis patients.

CAH Stock May Gain Following the Distribution Agreement With Telix

by Zacks Equity Research

Cardinal Health and Telix announce an agreement selecting the former as a commercial radiopharmaceutical distributor to supply finished unit doses of Telix's Zircaix.

Vasundhara Sawalka headshot

5 Stocks Trading Near 52-Week High With More Upside Potential

by Vasundhara Sawalka

Stocks like CCS, POWL, SLVM, IAG and UHS are seeing price strength and have a high chance of carrying the momentum forward.

Zubia Masood headshot

HCA Healthcare Stock Up 18.4% in 3 Months: Can You Afford to Miss Out?

by Zubia Masood

HCA benefits from expanding insurance coverage, rising demand and improving margins.

Here's Why You Should Retain Accuray Stock in Your Portfolio Now

by Zacks Equity Research

ARAY's solid product demand and revenue growth raise optimism about the stock.

NSPR Stock Declines Despite PMA Application Submission for CGuard

by Zacks Equity Research

InspireMD announces the submission of the PMA application to the FDA for marketing approval of the CGuard Prime EPS.

Tactile Medical's Shares Rise After PDAC Approval for Nimbl

by Zacks Equity Research

TCMD's Nimbl pneumatic compression system gets CMS PDAC approval and is set to be launched in the United States soon, following FDA clearance for treating lymphedema.

Community Health's Arm Northwest Urgent Buys 10 Arizona Facilities

by Zacks Equity Research

CYH expects the acquisition from Carbon Health to be completed in the fourth quarter of 2024.

Pediatrix Medical Up 45.8% in 3 Months: Is it Too Late to Jump In?

by Zacks Equity Research

MD remains one of the best-positioned pediatric service providers with favorable valuation to achieve margin improvement.

John Blank headshot

U.S. Fed Rate Cuts! Global Week Ahead

by John Blank

The Federal Reserve should deliver its first interest rate cut in four years, Brazil could hike for the first time since 2022 and Japan will be mindful of volatile markets.

CVRX Stock Gains on Unveiling of Barostim's Positive Study Data

by Zacks Equity Research

CVRx announces the publication of positive study data for its Barostim therapy.

Masimo Stock Likely to Rise With Qualcomm Wear OS Partnership

by Zacks Equity Research

MASI Collaborates with Qualcomm to develop a reference platform for Wear OS smartwatches, combining biosensing tech and Snapdragon chips to enhance performance and connectivity.

The Zacks Analyst Blog Ubiquiti, Spotify, DocuSign, Vertiv and Universal Health

by Zacks Equity Research

Ubiquiti, Spotify, DocuSign, Vertiv and Universal Health are included in this Analyst Blog.

Nalak Das headshot

Buy 5 Large-Cap Growth Stocks for September on Rate Cut Expectations

by Nalak Das

Investment in growth stocks should be fruitful on rate cut hope. Five growth stocks to be purchased for September are DOCU, SPOT, UI, UHS and VRT.

Merit Medical Gains 26.4% Year to Date: What's Driving the Stock?

by Zacks Equity Research

MMSI's shares gain on the back of strength in its Cardiovascular segment and a robust product portfolio.

SNN Stock Declines Despite the Launch of Its Patient-Matched Guides

by Zacks Equity Research

Smith & Nephew announces the launch of its TOTAL ANKLE Patient-Matched Guides to plan and perform total ankle replacement procedures.

iRhythm's Zio ECG System Gets Approval in Japan, Stock Falls

by Zacks Equity Research

IRTC's Zio ECG monitoring system gets approval in Japan, marking a significant step in revolutionizing arrhythmia diagnostics with AI-powered technology.

Cigna's Health Benefits Unit Launches a New E-Treatment Option

by Zacks Equity Research

CI's new launch, a new E-Treatment option, is expected to improve patient satisfaction and operational efficiency.